Those who take beta-blockers to control their blood pressure can often put on3lb. 吃β-受体阻滞药控制血压的人体重常会增加3磅。
Thrombolytic ( clot-dissolving) drugs may be administered. Beta-Blockers alleviate pain and slow the heart rate. 或许可以提供溶血栓药物。β阻断剂减轻疼痛并降低心跳速率。
Can you explain the challenge that beta-blockers present? 您能否解释一下阻断剂带来的挑战?
Even certain medications can trigger asthma: aspirin and other non-steroid anti-inflammatory drugs, and beta-blockers ( which are used to treat high blood pressure, heart conditions and migraine). 甚至某些药物也可诱发哮喘:阿斯匹林以及其它非甾体类消炎药和阻滞剂(用于治疗高血压、心脏病和偏头痛)。
This study only looked at patients who either were taking both ACE inhibitors and beta-blockers or were not taking either drug, he said. 本研究的重点在于,探讨ACE抑制剂及乙型阻断剂的使用,或其中一项药物在未被使用时,对患者会造成何种影响;
Beta-blockers reduced artifacts across the board, but were more useful for taming irregular heart rhythms than for slowing heart rates, the group noted. 贝塔受体阻滞剂可以在总体水平上减低为营,但它的作用不是降低心率,而是让心律更加规则。
If a patient is on hemodynamically sensitive medications, or is given beta-blockers prophylactically during surgery, for example, how does that affect the anesthesia provider's ability to gauge anesthetic depth? 如果一个患者在手术过程中使用血液动力学敏感药物,或者比如说预防的使用了阻断剂,这对麻醉师衡量麻醉深度的能力会有怎样的影响?
In patients treated with beta-blockers, venous leg ulcers occurred in18.2% of those exposed and17.7% of those not exposed. 在应用β-肾上腺素能受体阻断剂治疗的患者中,静脉溃疡的发生率是18.2%,而未接受的是17.7%。
New Evidence in the Role of Beta-Blockers on Management of Hypertension 从最新研究证据重新思考β受体阻滞剂在降压治疗中的地位
Current preventive strategies include the use of beta-blockers and antiarrhythmic drugs such as amiodarone and sotalol. 目前预防的主要措施包括:β受体阻滞剂的及抗心率失常药的使用,如胺碘酮和索他洛尔。
Hemodialysis can not improve patients 'cardiac autonomic nervous system impairment in uremia, while application of beta-blockers can; 常规血液透析不能改善尿毒症患者心脏自主神经损害,而β-受体阻滞剂治疗可明显改善尿毒症患者心脏自主神经损害,对延缓心血管并发症的发生有积极的预防作用;
Results Early use of low dosage of beta-blockers could improve all above variables of heart rate variability in acute myocardial infartion patients. 结果早期使用小剂量β-受体阻滞剂可使急性心肌梗死患者的心率变异的时域指标、散点图指标均有显著增加。
Objectives: To evaluate the value of catecholamine assessment in urine in predicting clinical efficacy of beta-blockers in the patients with vasovagal syncope. 目的:评价血管迷走性晕厥患者尿儿茶酚胺在β-阻滞剂疗效预测中的价值。
This article summarized the rationale for the cardiac protection of beta-blockers from all sides, such as inhibiting ischemical reperfusion injury, redressing chronic congestive heart failure, maintaining function of blood vessel and so on. 本文就β受体阻滞剂心肌保护作用的理论基础,在减少缺血再灌注损伤、纠正慢性充血性心力衰竭、保护血管功能等各个方面分别作一综述。
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis β受体阻断剂用于预防肝硬化患者出现胃食管静脉曲张
Conclusion Early use of beta-blockers in acute myocardial infartion patients could improve heart rate variability. This effect have no difference between anterior and inferior acute myocardial infarction. 结论对急性心肌梗死患者早期使用β-受体阻滞剂可显著改善患者的心率变异,这种作用在前壁心肌梗死与下壁心肌梗死之间无显著性差异。
Our aims are to give a brief summary of the latest development of its action mechanism and the impact of intravenous beta-blockers in the early stage of acute coronary syndrome. 本文拟就β受体阻滞剂作用机制的新进展、静脉β受体阻滞剂在急性冠脉综合征早期使用的相关研究及现状作一概述。
Effect of beta-blockers on the mortality of Japanese patients with myocardial infarction β受体阻断剂对日本心肌梗死患者死亡率的影响
Study on the interrelationship between the autonomic nervous impairment of haemodialysis patients and application of Beta-blockers 血液透析患者自主神经损伤及β-受体阻滞剂应用的临床研究
Compliance of Patients with Antihypertensive Therapy at Community in Shanghai Analysis of the use of Beta-blockers in congestive heart failure 社区高血压病人的药物利用与依从性关系分析β受体阻滞剂治疗充血性心力衰竭药物利用分析
Development of Intravenous Beta-Blockers in Early Stage of Acute Coronary Syndrome 静脉β受体阻滞剂在急性冠脉综合征的应用进展
Medical treatments included angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in 237 patients ( 84.7%) and beta-blockers in 168 ( 60.0%). 药物治疗中,血管紧张素转换酶抑制剂(ACE-Ⅰ)及血管紧张素Ⅱ受体拮抗剂(ARB)总使用率为84.7%,β-受体阻滞剂使用率为60.0%(168例)。
Western medicine usually treat it with nitric acid lipids, calcium antagonists and beta-blockers, but there are some side-effects, such as dizziness, flushing and low blood pressure. 西医常采用硝酸脂类、钙拮抗剂及β受体阻断剂等进行治疗,但存在头晕、面红、血压低等不良反应。因此副作用小、疗效显著的复方中药的研究越来越受人关注。
At the time of CRT device implantation, all patients were receiving optimal medications, including beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, spironolactone, and loop diuretics. 所有病人都得到最佳的药物治疗包括p他洛克阻滞剂,血管紧张素转换酶抑制剂,血管紧张素受体拮抗剂,螺内酯,利尿剂等。